CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 83 filers reported holding CARA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $439,144 | -71.6% | 1,702,110 | 0.0% | 0.04% | -76.8% |
Q1 2024 | $1,548,920 | +19.0% | 1,702,110 | -2.9% | 0.15% | +18.9% |
Q4 2023 | $1,301,819 | -55.9% | 1,752,112 | -0.3% | 0.13% | -66.2% |
Q3 2023 | $2,951,142 | -37.0% | 1,756,632 | +6.1% | 0.38% | -48.4% |
Q2 2023 | $4,685,280 | +82126.7% | 1,655,576 | +42.7% | 0.73% | -18.6% |
Q1 2023 | $5,698 | -54.3% | 1,160,392 | 0.0% | 0.90% | -69.3% |
Q4 2022 | $12,463 | -99.9% | 1,160,392 | 0.0% | 2.92% | +15.4% |
Q3 2022 | $10,861,000 | +2.5% | 1,160,392 | 0.0% | 2.53% | +1.2% |
Q2 2022 | $10,594,000 | -25.8% | 1,160,392 | -1.3% | 2.50% | +29.2% |
Q1 2022 | $14,281,000 | -10.1% | 1,175,392 | -9.9% | 1.94% | -8.7% |
Q4 2021 | $15,894,000 | -21.2% | 1,304,903 | 0.0% | 2.12% | -25.7% |
Q3 2021 | $20,161,000 | +8.3% | 1,304,903 | +0.0% | 2.86% | +39.8% |
Q2 2021 | $18,617,000 | -34.8% | 1,304,603 | -0.8% | 2.04% | -32.9% |
Q1 2021 | $28,540,000 | +43.5% | 1,314,603 | 0.0% | 3.04% | +25.5% |
Q4 2020 | $19,890,000 | +18.9% | 1,314,603 | +0.0% | 2.42% | -10.3% |
Q3 2020 | $16,725,000 | -34.1% | 1,314,303 | -11.5% | 2.70% | -36.7% |
Q2 2020 | $25,382,000 | +47.2% | 1,484,303 | +13.7% | 4.27% | +1.4% |
Q1 2020 | $17,244,000 | -17.6% | 1,305,409 | +0.4% | 4.22% | +36.9% |
Q4 2019 | $20,938,000 | -7.8% | 1,299,701 | +4.6% | 3.08% | -4.7% |
Q3 2019 | $22,707,000 | -4.2% | 1,242,201 | +12.7% | 3.23% | +36.7% |
Q2 2019 | $23,697,000 | +0.4% | 1,102,201 | -8.4% | 2.36% | -15.7% |
Q1 2019 | $23,604,000 | +50.7% | 1,203,055 | -0.1% | 2.80% | -25.9% |
Q4 2018 | $15,661,000 | -45.7% | 1,204,654 | 0.0% | 3.78% | +27.9% |
Q3 2018 | $28,851,000 | +29.4% | 1,204,654 | +3.5% | 2.96% | +14.6% |
Q2 2018 | $22,299,000 | +71.1% | 1,164,431 | +10.6% | 2.58% | +32.7% |
Q1 2018 | $13,035,000 | +3.1% | 1,052,933 | +1.9% | 1.94% | -5.7% |
Q4 2017 | $12,643,000 | -9.7% | 1,032,933 | +1.0% | 2.06% | -24.4% |
Q3 2017 | $14,003,000 | -10.7% | 1,022,890 | +0.4% | 2.72% | +3.0% |
Q2 2017 | $15,673,000 | -4.6% | 1,018,390 | +14.0% | 2.64% | +17.4% |
Q1 2017 | $16,429,000 | +158.1% | 893,390 | +30.4% | 2.25% | -3.6% |
Q4 2016 | $6,365,000 | – | 685,167 | – | 2.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,702,110 | $439,144 | 0.04% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,935,718 | $499,415 | 0.01% |
ADAR1 Capital Management, LLC | 159,469 | $41,143 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 414,731 | $107,001 | 0.01% |
FARALLON CAPITAL MANAGEMENT LLC | 1,556,251 | $401,513 | 0.00% |
Virtu Financial LLC | 75,987 | $20 | 0.00% |
Corsair Capital Management | 19,864 | $5,125 | 0.00% |
WEALTH EFFECTS LLC | 13,500 | $3,483 | 0.00% |
Cypress Capital Management LLC (WY) | 5,000 | $1,290 | 0.00% |
Citadel Advisors | 5,000 | $1,290 | 0.00% |